Skip to main content
2023 IKCS: Europe Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Tumor Biology, Biomarkers, and Pathology

SESSION 4: ORAL ABSTRACTS

Oral Abstract: Baseline circulating soluble factors as predictors of benefit from nivolumab in metastatic renal cell carcinoma (mRCC): additional multivariate analyses of the pooled translational NIVOREN GETUG-AFU26 population

Friday, April 21, 2023
14:57 – 15:07 GMT
Location: Lenox 3
Full abstract will be available on April 17, 2023.